Pharmaceutical Grade Marijuana-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Pharmaceutical Grade Marijuana-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical Grade Marijuana industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pharmaceutical Grade Marijuana 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical Grade Marijuana worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical Grade Marijuana market
Market status and development trend of Pharmaceutical Grade Marijuana by types and applications
Cost and profit status of Pharmaceutical Grade Marijuana, and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical Grade Marijuana market as:
Global Pharmaceutical Grade Marijuana Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pharmaceutical Grade Marijuana Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Sativex
Cesamet
Marinol
Dexanabinol
Cannabinor
Others
Global Pharmaceutical Grade Marijuana Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Hospitals
Global Pharmaceutical Grade Marijuana Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical Grade Marijuana Sales Volume, Revenue, Price and Gross Margin):
Merck
Pharmos
GW Pharmaceuticals
Valeant Pharmaceuticals International
Unimed Pharmaceuticals
Solvay Pharmaceuticals
Sanofi-Aventis
Medical Marijuana Inc
Teva Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmaceutical Grade Marijuana-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical Grade Marijuana industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pharmaceutical Grade Marijuana 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical Grade Marijuana worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical Grade Marijuana market
Market status and development trend of Pharmaceutical Grade Marijuana by types and applications
Cost and profit status of Pharmaceutical Grade Marijuana, and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical Grade Marijuana market as:
Global Pharmaceutical Grade Marijuana Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pharmaceutical Grade Marijuana Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Sativex
Cesamet
Marinol
Dexanabinol
Cannabinor
Others
Global Pharmaceutical Grade Marijuana Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Hospitals
Global Pharmaceutical Grade Marijuana Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical Grade Marijuana Sales Volume, Revenue, Price and Gross Margin):
Merck
Pharmos
GW Pharmaceuticals
Valeant Pharmaceuticals International
Unimed Pharmaceuticals
Solvay Pharmaceuticals
Sanofi-Aventis
Medical Marijuana Inc
Teva Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACEUTICAL GRADE MARIJUANA
1.1 Definition of Pharmaceutical Grade Marijuana in This Report
1.2 Commercial Types of Pharmaceutical Grade Marijuana
1.2.1 Sativex
1.2.2 Cesamet
1.2.3 Marinol
1.2.4 Dexanabinol
1.2.5 Cannabinor
1.2.6 Others
1.3 Downstream Application of Pharmaceutical Grade Marijuana
1.3.1 Research & Academic Laboratories
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals
1.4 Development History of Pharmaceutical Grade Marijuana
1.5 Market Status and Trend of Pharmaceutical Grade Marijuana 2013-2023
1.5.1 Global Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical Grade Marijuana 2013-2017
2.2 Sales Market of Pharmaceutical Grade Marijuana by Regions
2.2.1 Sales Volume of Pharmaceutical Grade Marijuana by Regions
2.2.2 Sales Value of Pharmaceutical Grade Marijuana by Regions
2.3 Production Market of Pharmaceutical Grade Marijuana by Regions
2.4 Global Market Forecast of Pharmaceutical Grade Marijuana 2018-2023
2.4.1 Global Market Forecast of Pharmaceutical Grade Marijuana 2018-2023
2.4.2 Market Forecast of Pharmaceutical Grade Marijuana by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pharmaceutical Grade Marijuana by Types
3.2 Sales Value of Pharmaceutical Grade Marijuana by Types
3.3 Market Forecast of Pharmaceutical Grade Marijuana by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pharmaceutical Grade Marijuana by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical Grade Marijuana by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pharmaceutical Grade Marijuana Market Status by Countries
5.1.1 North America Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
5.1.2 North America Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
5.1.3 United States Pharmaceutical Grade Marijuana Market Status (2013-2017)
5.1.4 Canada Pharmaceutical Grade Marijuana Market Status (2013-2017)
5.1.5 Mexico Pharmaceutical Grade Marijuana Market Status (2013-2017)
5.2 North America Pharmaceutical Grade Marijuana Market Status by Manufacturers
5.3 North America Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
5.3.1 North America Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
5.3.2 North America Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
5.4 North America Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pharmaceutical Grade Marijuana Market Status by Countries
6.1.1 Europe Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
6.1.2 Europe Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
6.1.3 Germany Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.4 UK Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.5 France Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.6 Italy Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.7 Russia Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.8 Spain Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.9 Benelux Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.2 Europe Pharmaceutical Grade Marijuana Market Status by Manufacturers
6.3 Europe Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
6.3.1 Europe Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
6.3.2 Europe Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
6.4 Europe Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Countries
7.1.1 Asia Pacific Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
7.1.3 China Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.4 Japan Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.5 India Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.6 Southeast Asia Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.7 Australia Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.2 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
7.3.2 Asia Pacific Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
7.4 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pharmaceutical Grade Marijuana Market Status by Countries
8.1.1 Latin America Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
8.1.2 Latin America Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
8.1.3 Brazil Pharmaceutical Grade Marijuana Market Status (2013-2017)
8.1.4 Argentina Pharmaceutical Grade Marijuana Market Status (2013-2017)
8.1.5 Colombia Pharmaceutical Grade Marijuana Market Status (2013-2017)
8.2 Latin America Pharmaceutical Grade Marijuana Market Status by Manufacturers
8.3 Latin America Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
8.3.1 Latin America Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
8.3.2 Latin America Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
8.4 Latin America Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Countries
9.1.1 Middle East and Africa Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
9.1.3 Middle East Pharmaceutical Grade Marijuana Market Status (2013-2017)
9.1.4 Africa Pharmaceutical Grade Marijuana Market Status (2013-2017)
9.2 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
9.4 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical Grade Marijuana Downstream Industry Situation and Trend Overview
CHAPTER 11 PHARMACEUTICAL GRADE MARIJUANA MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pharmaceutical Grade Marijuana by Major Manufacturers
11.2 Production Value of Pharmaceutical Grade Marijuana by Major Manufacturers
11.3 Basic Information of Pharmaceutical Grade Marijuana by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pharmaceutical Grade Marijuana Major Manufacturer
11.3.2 Employees and Revenue Level of Pharmaceutical Grade Marijuana Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHARMACEUTICAL GRADE MARIJUANA MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Merck
12.1.1 Company profile
12.1.2 Representative Pharmaceutical Grade Marijuana Product
12.1.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Merck
12.2 Pharmos
12.2.1 Company profile
12.2.2 Representative Pharmaceutical Grade Marijuana Product
12.2.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Pharmos
12.3 GW Pharmaceuticals
12.3.1 Company profile
12.3.2 Representative Pharmaceutical Grade Marijuana Product
12.3.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of GW Pharmaceuticals
12.4 Valeant Pharmaceuticals International
12.4.1 Company profile
12.4.2 Representative Pharmaceutical Grade Marijuana Product
12.4.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
12.5 Unimed Pharmaceuticals
12.5.1 Company profile
12.5.2 Representative Pharmaceutical Grade Marijuana Product
12.5.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Unimed Pharmaceuticals
12.6 Solvay Pharmaceuticals
12.6.1 Company profile
12.6.2 Representative Pharmaceutical Grade Marijuana Product
12.6.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Solvay Pharmaceuticals
12.7 Sanofi-Aventis
12.7.1 Company profile
12.7.2 Representative Pharmaceutical Grade Marijuana Product
12.7.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
12.8 Medical Marijuana Inc
12.8.1 Company profile
12.8.2 Representative Pharmaceutical Grade Marijuana Product
12.8.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Medical Marijuana Inc
12.9 Teva Pharmaceutical
12.9.1 Company profile
12.9.2 Representative Pharmaceutical Grade Marijuana Product
12.9.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
13.1 Industry Chain of Pharmaceutical Grade Marijuana
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
14.1 Cost Structure Analysis of Pharmaceutical Grade Marijuana
14.2 Raw Materials Cost Analysis of Pharmaceutical Grade Marijuana
14.3 Labor Cost Analysis of Pharmaceutical Grade Marijuana
14.4 Manufacturing Expenses Analysis of Pharmaceutical Grade Marijuana
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Pharmaceutical Grade Marijuana in This Report
1.2 Commercial Types of Pharmaceutical Grade Marijuana
1.2.1 Sativex
1.2.2 Cesamet
1.2.3 Marinol
1.2.4 Dexanabinol
1.2.5 Cannabinor
1.2.6 Others
1.3 Downstream Application of Pharmaceutical Grade Marijuana
1.3.1 Research & Academic Laboratories
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals
1.4 Development History of Pharmaceutical Grade Marijuana
1.5 Market Status and Trend of Pharmaceutical Grade Marijuana 2013-2023
1.5.1 Global Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Grade Marijuana Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical Grade Marijuana 2013-2017
2.2 Sales Market of Pharmaceutical Grade Marijuana by Regions
2.2.1 Sales Volume of Pharmaceutical Grade Marijuana by Regions
2.2.2 Sales Value of Pharmaceutical Grade Marijuana by Regions
2.3 Production Market of Pharmaceutical Grade Marijuana by Regions
2.4 Global Market Forecast of Pharmaceutical Grade Marijuana 2018-2023
2.4.1 Global Market Forecast of Pharmaceutical Grade Marijuana 2018-2023
2.4.2 Market Forecast of Pharmaceutical Grade Marijuana by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pharmaceutical Grade Marijuana by Types
3.2 Sales Value of Pharmaceutical Grade Marijuana by Types
3.3 Market Forecast of Pharmaceutical Grade Marijuana by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pharmaceutical Grade Marijuana by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical Grade Marijuana by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pharmaceutical Grade Marijuana Market Status by Countries
5.1.1 North America Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
5.1.2 North America Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
5.1.3 United States Pharmaceutical Grade Marijuana Market Status (2013-2017)
5.1.4 Canada Pharmaceutical Grade Marijuana Market Status (2013-2017)
5.1.5 Mexico Pharmaceutical Grade Marijuana Market Status (2013-2017)
5.2 North America Pharmaceutical Grade Marijuana Market Status by Manufacturers
5.3 North America Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
5.3.1 North America Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
5.3.2 North America Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
5.4 North America Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pharmaceutical Grade Marijuana Market Status by Countries
6.1.1 Europe Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
6.1.2 Europe Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
6.1.3 Germany Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.4 UK Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.5 France Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.6 Italy Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.7 Russia Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.8 Spain Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.1.9 Benelux Pharmaceutical Grade Marijuana Market Status (2013-2017)
6.2 Europe Pharmaceutical Grade Marijuana Market Status by Manufacturers
6.3 Europe Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
6.3.1 Europe Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
6.3.2 Europe Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
6.4 Europe Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Countries
7.1.1 Asia Pacific Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
7.1.3 China Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.4 Japan Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.5 India Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.6 Southeast Asia Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.1.7 Australia Pharmaceutical Grade Marijuana Market Status (2013-2017)
7.2 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
7.3.2 Asia Pacific Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
7.4 Asia Pacific Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pharmaceutical Grade Marijuana Market Status by Countries
8.1.1 Latin America Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
8.1.2 Latin America Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
8.1.3 Brazil Pharmaceutical Grade Marijuana Market Status (2013-2017)
8.1.4 Argentina Pharmaceutical Grade Marijuana Market Status (2013-2017)
8.1.5 Colombia Pharmaceutical Grade Marijuana Market Status (2013-2017)
8.2 Latin America Pharmaceutical Grade Marijuana Market Status by Manufacturers
8.3 Latin America Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
8.3.1 Latin America Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
8.3.2 Latin America Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
8.4 Latin America Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Countries
9.1.1 Middle East and Africa Pharmaceutical Grade Marijuana Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pharmaceutical Grade Marijuana Revenue by Countries (2013-2017)
9.1.3 Middle East Pharmaceutical Grade Marijuana Market Status (2013-2017)
9.1.4 Africa Pharmaceutical Grade Marijuana Market Status (2013-2017)
9.2 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pharmaceutical Grade Marijuana Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pharmaceutical Grade Marijuana Revenue by Type (2013-2017)
9.4 Middle East and Africa Pharmaceutical Grade Marijuana Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical Grade Marijuana Downstream Industry Situation and Trend Overview
CHAPTER 11 PHARMACEUTICAL GRADE MARIJUANA MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pharmaceutical Grade Marijuana by Major Manufacturers
11.2 Production Value of Pharmaceutical Grade Marijuana by Major Manufacturers
11.3 Basic Information of Pharmaceutical Grade Marijuana by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pharmaceutical Grade Marijuana Major Manufacturer
11.3.2 Employees and Revenue Level of Pharmaceutical Grade Marijuana Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHARMACEUTICAL GRADE MARIJUANA MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Merck
12.1.1 Company profile
12.1.2 Representative Pharmaceutical Grade Marijuana Product
12.1.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Merck
12.2 Pharmos
12.2.1 Company profile
12.2.2 Representative Pharmaceutical Grade Marijuana Product
12.2.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Pharmos
12.3 GW Pharmaceuticals
12.3.1 Company profile
12.3.2 Representative Pharmaceutical Grade Marijuana Product
12.3.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of GW Pharmaceuticals
12.4 Valeant Pharmaceuticals International
12.4.1 Company profile
12.4.2 Representative Pharmaceutical Grade Marijuana Product
12.4.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
12.5 Unimed Pharmaceuticals
12.5.1 Company profile
12.5.2 Representative Pharmaceutical Grade Marijuana Product
12.5.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Unimed Pharmaceuticals
12.6 Solvay Pharmaceuticals
12.6.1 Company profile
12.6.2 Representative Pharmaceutical Grade Marijuana Product
12.6.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Solvay Pharmaceuticals
12.7 Sanofi-Aventis
12.7.1 Company profile
12.7.2 Representative Pharmaceutical Grade Marijuana Product
12.7.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
12.8 Medical Marijuana Inc
12.8.1 Company profile
12.8.2 Representative Pharmaceutical Grade Marijuana Product
12.8.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Medical Marijuana Inc
12.9 Teva Pharmaceutical
12.9.1 Company profile
12.9.2 Representative Pharmaceutical Grade Marijuana Product
12.9.3 Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
13.1 Industry Chain of Pharmaceutical Grade Marijuana
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL GRADE MARIJUANA
14.1 Cost Structure Analysis of Pharmaceutical Grade Marijuana
14.2 Raw Materials Cost Analysis of Pharmaceutical Grade Marijuana
14.3 Labor Cost Analysis of Pharmaceutical Grade Marijuana
14.4 Manufacturing Expenses Analysis of Pharmaceutical Grade Marijuana
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
